Forest Labs and Janssen terminated the licenses in Canada for both Bystolic and Savella (milnacipran) with Janssen Pharmaceutica NV and...
Depomed, Inc. announced that it has acquired all United States and Canadian rights to Lazanda (fentanyl) nasal spray from Archimedes...
The objective of our review was to systematically evaluate the quality of evidence from the literature to formulate evidence-based guidelines for the diagnosis and management of patients with Pompe disease.
Aralez Pharmaceuticals Inc. announced that it acquired the U.S. and Canadian rights to Zontivity (vorapaxar), pursuant to an asset purchase...
Novo Nordisk has announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights...
Vanda Pharmaceuticals Inc. announced that it has acquired U.S. and Canadian rights to Ponvory (ponesimod) from Actelion Pharmaceuticals Ltd. (Janssen), a Johnson & Johnson Company.
Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases.
Hidradenitis suppurativa is a chronic inflammatory disorder affecting hair follicles, with profoundly negative impact on patient quality of life.
Evolus, Inc. announced the presentation of data from the Phase III comparative clinical trial of its investigational prabotulinumtoxinA 900 kilodalton...
Sandoz, a Novartis division, announced that it has entered into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT 1706).